Filing Details
- Accession Number:
- 0001209191-14-017514
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-03-05 17:45:53
- Reporting Period:
- 2014-03-04
- Filing Date:
- 2014-03-05
- Accepted Time:
- 2014-03-05 17:45:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1267602 | Alimera Sciences Inc | ALIM | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1489530 | Susan Caballa | 6120 Windward Parkway, Suite 290 Alpharetta GA 30005 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-03-04 | 8,931 | $2.04 | 86,363 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-03-04 | 8,931 | $7.01 | 77,432 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2014-03-04 | 8,931 | $0.00 | 8,931 | $2.04 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2014-07-07 | No | 4 | M | Direct |
Footnotes
- Includes an aggregate of 6,445 shares of common stock acquired under the Alimera Sciences, Inc. 2010 Employee Stock Purchase Plan on October 31, 2012, April 30, 2013 and October 31, 2013.
- Became exercisable with respect to 1/4 of the shares of stock which are subject to this option on 7/7/05 (the "Initial Vesting Date") and with respect to the remainder of the shares in equal increments quarterly over three years beginning on the date three (3) months from the Initial Vesting Date.